INVOKANA ® (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news